• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

度普利尤单抗对特应性皮炎患者先天性淋巴细胞和辅助性T细胞群体的影响。

Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis.

作者信息

Imai Yasutomo, Kusakabe Minori, Nagai Makoto, Yasuda Koubun, Yamanishi Kiyofumi

机构信息

Department of Dermatology, Hyogo College of Medicine, Nishinomiya, Japan.

Department of Immunology, Hyogo College of Medicine, Nishinomiya, Japan.

出版信息

JID Innov. 2021 Feb 20;1(1):100003. doi: 10.1016/j.xjidi.2021.100003. eCollection 2021 Mar.

DOI:10.1016/j.xjidi.2021.100003
PMID:34909707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8659712/
Abstract

Group 2 innate lymphoid cells (ILCs) are thought to contribute to the pathogenesis of atopic dermatitis (AD). IL-4 stimulates T helper type 2 (Th2) cells and ILC2s to proliferate and produce cytokines. Dupilumab, an antibody against the IL-4 receptor, is used in AD therapy. We speculated that its efficacy might involve blocking the activation of Th2 cells and ILC2s via IL-4. Here, we examined circulating Th2 cells and ILC2s in 27 Japanese patients with AD before and after the administration of dupilumab. Between 0 and 4 months after dupilumab administration, the percentages of Th2 cells and ILC2s were decreased. Notably, ILC2/3 ratio was decreased after dupilumab treatment. Interestingly, ILC2/3 ratio before dupilumab treatment were significantly higher in high responders than in low responders to dupilumab. To resolve the molecular signatures of the Th2 and ILC2s in AD, we sorted CD4 T cells and ILCs from peripheral blood and analyzed their transcriptomes using the BD Rhapsody Single-cell RNA sequencing system. Between 0 and 4 months after dupilumab administration, the Th2 and ILC2 cluster gene signatures were downregulated. Thus, dupilumab might improve dermatitis by suppressing the Th2 cell and ILC2 populations and altering the Th2 and ILC2 repertoire in patients with AD.

摘要

第2组固有淋巴细胞(ILC)被认为与特应性皮炎(AD)的发病机制有关。白细胞介素-4(IL-4)刺激2型辅助性T细胞(Th2)和ILC2增殖并产生细胞因子。度普利尤单抗是一种抗IL-4受体的抗体,用于AD治疗。我们推测其疗效可能涉及通过IL-4阻断Th2细胞和ILC2的激活。在此,我们检测了27例日本AD患者在使用度普利尤单抗前后循环中的Th2细胞和ILC2。在使用度普利尤单抗后的0至4个月内,Th2细胞和ILC2的百分比下降。值得注意的是,度普利尤单抗治疗后ILC2/3比值下降。有趣的是,在度普利尤单抗治疗前,高反应者的ILC2/3比值显著高于低反应者。为了解决AD中Th2和ILC2的分子特征,我们从外周血中分选了CD4 T细胞和ILC,并使用BD Rhapsody单细胞RNA测序系统分析了它们的转录组。在使用度普利尤单抗后的0至4个月内,Th2和ILC2簇基因特征下调。因此,度普利尤单抗可能通过抑制AD患者的Th2细胞和ILC2群体并改变Th2和ILC2组成来改善皮炎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/6bfd18546c43/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/edee243d3354/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/12250584a1c5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/0d2fb5d76338/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/6bfd18546c43/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/edee243d3354/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/12250584a1c5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/0d2fb5d76338/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/27c9/8659712/6bfd18546c43/gr3.jpg

相似文献

1
Dupilumab Effects on Innate Lymphoid Cell and Helper T Cell Populations in Patients with Atopic Dermatitis.度普利尤单抗对特应性皮炎患者先天性淋巴细胞和辅助性T细胞群体的影响。
JID Innov. 2021 Feb 20;1(1):100003. doi: 10.1016/j.xjidi.2021.100003. eCollection 2021 Mar.
2
ILC2s in skin disorders.皮肤疾病中的2型固有淋巴细胞
Allergol Int. 2023 Apr;72(2):201-206. doi: 10.1016/j.alit.2023.01.002. Epub 2023 Feb 24.
3
Group 2 innate lymphoid cells (ILC2s) are important in typical type 2 immune-mediated diseases and an essential therapeutic target.2 型固有淋巴细胞(ILC2s)在典型的 2 型免疫介导性疾病中具有重要作用,是一个重要的治疗靶点。
J Int Med Res. 2022 Jan;50(1):3000605211053156. doi: 10.1177/03000605211053156.
4
Monitoring Cellular Movement with Photoconvertible Fluorescent Protein and Single-Cell RNA Sequencing Reveals Cutaneous Group 2 Innate Lymphoid Cell Subtypes, Circulating ILC2 and Skin-Resident ILC2.利用光转化荧光蛋白和单细胞RNA测序监测细胞运动揭示了皮肤2型天然淋巴细胞亚群、循环ILC2和皮肤驻留ILC2。
JID Innov. 2021 Jul 2;1(3):100035. doi: 10.1016/j.xjidi.2021.100035. eCollection 2021 Sep.
5
Increased frequencies of basophils, type 2 innate lymphoid cells and Th2 cells in skin of patients with atopic dermatitis but not psoriasis.特应性皮炎患者皮肤中嗜碱性粒细胞、2 型先天淋巴样细胞和 Th2 细胞的频率增加,但银屑病患者则不然。
J Dermatol Sci. 2017 Nov;88(2):167-174. doi: 10.1016/j.jdermsci.2017.07.003. Epub 2017 Jul 15.
6
Circulating T Cell Subsets and ILC2s are Altered in Patients With Chronic Rhinosinusitis With Nasal Polyps After Dupilumab Treatment.在接受度普利尤单抗治疗后,慢性鼻-鼻窦炎伴鼻息肉患者的循环 T 细胞亚群和 ILC2 发生改变。
Am J Rhinol Allergy. 2023 Jan;37(1):58-64. doi: 10.1177/19458924221132065. Epub 2022 Oct 9.
7
Elevated circulating Th2 but not group 2 innate lymphoid cell responses characterize canine atopic dermatitis.循环中Th2细胞反应升高而非2型固有淋巴细胞反应升高是犬特应性皮炎的特征。
Vet Immunol Immunopathol. 2020 Mar;221:110015. doi: 10.1016/j.vetimm.2020.110015. Epub 2020 Jan 24.
8
IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice.IL-33 诱导的角膜结膜炎是由小鼠中的 2 类固有淋巴细胞介导的。
Allergol Int. 2023 Apr;72(2):324-331. doi: 10.1016/j.alit.2022.10.003. Epub 2022 Oct 29.
9
Peripheral blood mononuclear cell- transcriptome signatures of atopic dermatitis and prediction for the efficacy of dupilumab.特应性皮炎的外周血单个核细胞转录组特征及度普利尤单抗疗效预测
J Dermatol Sci. 2023 Sep;111(3):83-92. doi: 10.1016/j.jdermsci.2023.06.002. Epub 2023 Jun 8.
10
IL-13 Type 2 Innate Lymphoid Cells Correlate with Asthma Control Status and Treatment Response.IL-13 2型固有淋巴细胞与哮喘控制状态及治疗反应相关。
Am J Respir Cell Mol Biol. 2016 Nov;55(5):675-683. doi: 10.1165/rcmb.2016-0099OC.

引用本文的文献

1
Effect of dupilumab for the therapy of atopic dermatitis and the effect on serum TARC, HBD2 and SEA-IgE levels and peripheral blood T helper cell subtypes.度普利尤单抗治疗特应性皮炎的疗效及其对血清胸腺和活化调节趋化因子、人β-防御素2及特异性IgE水平和外周血辅助性T细胞亚群的影响。
Exp Ther Med. 2025 May 16;30(1):138. doi: 10.3892/etm.2025.12888. eCollection 2025 Jul.
2
An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis.一项无偏倚的组织转录组分析确定了特应性皮炎皮肤表型和治疗反应的潜在标志物。
Nat Commun. 2025 Jun 2;16(1):4981. doi: 10.1038/s41467-025-59340-x.
3

本文引用的文献

1
Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients.度普利尤单抗治疗253例成年特应性皮炎患者长达52周的长期疗效。
Br J Dermatol. 2021 Mar;184(3):561-563. doi: 10.1111/bjd.19577. Epub 2020 Nov 18.
2
Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients.度普利尤单抗治疗不同表型特应性皮炎的疗效:221例患者的一年经验
J Clin Med. 2020 Aug 19;9(9):2684. doi: 10.3390/jcm9092684.
3
T cell diversity and response to dupilumab in patients with atopic dermatitis.
T cell immunophenotypes and IgE responses in patients with moderate-to-severe atopic dermatitis receiving dupilumab.
接受度普利尤单抗治疗的中重度特应性皮炎患者的T细胞免疫表型和IgE反应
Clin Transl Allergy. 2025 May;15(5):e70062. doi: 10.1002/clt2.70062.
4
The role of ILC2s in asthma combined with atopic dermatitis: bridging the gap from research to clinical practice.2型固有淋巴细胞在哮喘合并特应性皮炎中的作用:弥合从研究到临床实践的差距
Front Immunol. 2025 Apr 1;16:1567817. doi: 10.3389/fimmu.2025.1567817. eCollection 2025.
5
What is "eczema"?什么是“湿疹”?
J Dermatol. 2025 Feb;52(2):192-203. doi: 10.1111/1346-8138.17439. Epub 2024 Sep 20.
6
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective.合并症和特殊人群的中重度特应性皮炎患者的生物制剂和小分子治疗:意大利视角
Dermatol Reports. 2023 Sep 13;16(2):9839. doi: 10.4081/dr.2023.9839. eCollection 2024 Jun 14.
7
The Possible Roles of IL-4/IL-13 in the Development of Eosinophil-Predominant Severe Asthma.IL-4/IL-13 在嗜酸性粒细胞为主的重症哮喘发病中的可能作用
Biomolecules. 2024 May 2;14(5):546. doi: 10.3390/biom14050546.
8
How Do Classical Subtypes Correspond to Endotypes in Atopic Dermatitis?特应性皮炎的经典亚型与表型如何对应?
Int J Mol Sci. 2023 Dec 23;25(1):265. doi: 10.3390/ijms25010265.
9
Multifaceted analysis of cross-tissue transcriptomes reveals phenotype-endotype associations in atopic dermatitis.多层面分析组织间转录组学揭示特应性皮炎的表型-内型关联。
Nat Commun. 2023 Oct 2;14(1):6133. doi: 10.1038/s41467-023-41857-8.
10
Versatile roles of innate lymphoid cells at the mucosal barrier: from homeostasis to pathological inflammation.先天淋巴细胞在黏膜屏障中的多功能作用:从稳态到病理性炎症。
Exp Mol Med. 2023 Sep;55(9):1845-1857. doi: 10.1038/s12276-023-01022-z. Epub 2023 Sep 11.
特应性皮炎患者的T细胞多样性及对度普利尤单抗的反应
J Allergy Clin Immunol. 2021 Feb;147(2):756-759. doi: 10.1016/j.jaci.2020.05.037. Epub 2020 Jun 8.
4
Single-cell transcriptomics combined with interstitial fluid proteomics defines cell type-specific immune regulation in atopic dermatitis.单细胞转录组学联合细胞间液蛋白质组学定义特应性皮炎中细胞类型特异性免疫调节。
J Allergy Clin Immunol. 2020 Nov;146(5):1056-1069. doi: 10.1016/j.jaci.2020.03.041. Epub 2020 Apr 25.
5
Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis.单细胞转录组分析人类皮肤鉴定新型成纤维细胞亚群和特应性皮炎中免疫亚群的富集。
J Allergy Clin Immunol. 2020 Jun;145(6):1615-1628. doi: 10.1016/j.jaci.2020.01.042. Epub 2020 Feb 7.
6
Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1.鉴定由 FoxM1 调控的新型关节炎相关破骨细胞前体细胞巨噬细胞。
Nat Immunol. 2019 Dec;20(12):1631-1643. doi: 10.1038/s41590-019-0526-7. Epub 2019 Nov 18.
7
Interleukin-33 in atopic dermatitis.白细胞介素-33 在特应性皮炎中的作用。
J Dermatol Sci. 2019 Oct;96(1):2-7. doi: 10.1016/j.jdermsci.2019.08.006. Epub 2019 Aug 19.
8
IL-33-Induced Atopic Dermatitis-Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with Basophils.IL-33 诱导的小鼠特应性皮炎样炎症是由 2 类固有淋巴细胞与嗜碱性粒细胞协同作用介导的。
J Invest Dermatol. 2019 Oct;139(10):2185-2194.e3. doi: 10.1016/j.jid.2019.04.016. Epub 2019 May 21.
9
Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.度普利尤单抗可改善特应性皮炎患者的全身性和皮肤异常。
J Allergy Clin Immunol. 2019 Jan;143(1):155-172. doi: 10.1016/j.jaci.2018.08.022. Epub 2018 Sep 5.
10
An interpretable framework for clustering single-cell RNA-Seq datasets.用于聚类单细胞 RNA-Seq 数据集的可解释框架。
BMC Bioinformatics. 2018 Mar 9;19(1):93. doi: 10.1186/s12859-018-2092-7.